Trials / Completed
CompletedNCT01611415
Drug to Drug Interaction Study With Ipragliflozin and Furosemide
A Clinical Pharmacological Study to Assess Pharmacodynamic and Pharmacokinetic Interactions Between Furosemide and Ipragliflozin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Astellas Pharma Europe B.V. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study to investigate if there are any pharmacodynamic and pharmacokinetic interactions between furosemide and ipragliflozin (ASP1941) in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ipragliflozin | Oral |
| DRUG | Furosemide | Oral |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2012-06-05
- Last updated
- 2012-06-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01611415. Inclusion in this directory is not an endorsement.